Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

Gene Biotherapeutics, Inc. CRXM

Set alert

Price alert · CRXM

All alert types
0.00 0.00 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
6.49K
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
More statistics
Low
—
High
—
Earnings
Oct 27, 2016

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for CRXM has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-308.12 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -1.6×
FY 2011: -3.5×FY 2012: -2.7×FY 2013: -0.6×FY 2014: -0.4×FY 2015: -1.1×FY 2016: -0.7×FY 2017: -0.8×FY 2018: -1.7×FY 2019: 3.1×FY 2020: -1.6×
FY 2011 5y median -0.8× FY 2020
P/S 0.0×
FY 2011: 0.0×FY 2012: 28.7×FY 2013: 53.2×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×
FY 2011 5y median 0.0× FY 2020
P/B -0.2×
FY 2011: 4.1×FY 2012: 3.5×FY 2013: 4.9×FY 2014: -1.2×FY 2015: -1.1×FY 2016: -0.6×FY 2017: -0.3×FY 2018: -0.1×FY 2019: -0.6×FY 2020: -0.2×
FY 2011 5y median -0.3× FY 2020
P/FCF -0.8×
FY 2011: -3.2×FY 2012: -2.4×FY 2013: -1.0×FY 2014: -0.8×FY 2015: -4.0×FY 2016: -0.9×FY 2017: -1.3×FY 2018: -1.6×FY 2019: -19.5×FY 2020: -0.8×
FY 2011 5y median -1.3× FY 2020
EV/EBITDA -1.4×
FY 2011: -2.9×FY 2012: -2.5×FY 2013: -0.9×FY 2014: -0.7×FY 2015: -1.7×FY 2016: -0.8×FY 2017: -1.3×FY 2018: -3.8×FY 2019: -4.9×FY 2020: -1.4×
FY 2011 5y median -1.4× FY 2020
EV/Sales 0.0×
FY 2011: 0.0×FY 2012: 25.7×FY 2013: 53.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×
FY 2011 5y median 0.0× FY 2020
FCF Yield -124.0%
FY 2011: -31.0%FY 2012: -41.0%FY 2013: -104.2%FY 2014: -125.1%FY 2015: -24.8%FY 2016: -108.0%FY 2017: -74.3%FY 2018: -61.1%FY 2019: -5.1%FY 2020: -124.0%
FY 2011 5y median -74.3% FY 2020

Profitability

Gross Margin 0.0%
FY 2011: 0.0%FY 2012: 44.3%FY 2013: 36.7%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%
FY 2011 5y median 0.0% FY 2020
Operating Margin 0.0%
FY 2011: 0.0%FY 2012: -1068.4%FY 2013: -6324.4%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%
FY 2011 5y median 0.0% FY 2020
Net Margin 0.0%
FY 2011: 0.0%FY 2012: -1059.8%FY 2013: -8163.3%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%
FY 2011 5y median 0.0% FY 2020
ROE 13.4%
FY 2011: -117.2%FY 2012: -130.7%FY 2013: -752.2%FY 2014: 327.4%FY 2015: 97.5%FY 2016: 93.0%FY 2017: 39.4%FY 2018: 8.4%FY 2019: -20.2%FY 2020: 13.4%
FY 2011 5y median 13.4% FY 2020
ROIC 38.2%
FY 2011: -119.5%FY 2012: -130.8%FY 2013: -582.8%FY 2014: 212.6%FY 2015: 109.4%FY 2016: 127.3%FY 2017: 53.0%FY 2018: 11.2%FY 2019: 22.4%FY 2020: 38.2%
FY 2011 5y median 38.2% FY 2020
ROA -91.4%
FY 2011: -95.0%FY 2012: -106.6%FY 2013: -319.9%FY 2014: -738.0%FY 2015: -9913.4%FY 2016: -262.7%FY 2017: -902.9%FY 2018: -268.7%FY 2019: 2445.8%FY 2020: -91.4%
FY 2011 5y median -262.7% FY 2020

Growth (YoY)

Revenue 0.0%
FY 2011: -100.0%FY 2012: 0.0%FY 2013: -86.1%FY 2014: -100.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%
FY 2011 FY 2020
Operating Income -50.8%
FY 2011: -9.6%FY 2012: -13.1%FY 2013: 17.7%FY 2014: 48.2%FY 2015: 12.9%FY 2016: 8.8%FY 2017: 26.9%FY 2018: 75.3%FY 2019: -63.2%FY 2020: -50.8%
FY 2011 FY 2020
EPS (diluted) -140.0%
FY 2011: -31.2%FY 2012: 16.1%FY 2013: 5.7%FY 2014: 62.4%FY 2015: 42.0%FY 2016: 24.1%FY 2017: 40.9%FY 2018: 76.8%FY 2019: 298.0%FY 2020: -140.0%
FY 2011 FY 2020
Free Cash Flow -728.5%
FY 2011: -2.8%FY 2012: -20.2%FY 2013: 34.5%FY 2014: 59.3%FY 2015: 57.2%FY 2016: -108.5%FY 2017: 51.6%FY 2018: 57.5%FY 2019: 69.6%FY 2020: -728.5%
FY 2011 FY 2020

Financial Health

Current Ratio 0.1×
FY 2011: 4.1×FY 2012: 3.1×FY 2013: 0.3×FY 2014: 0.2×FY 2015: 0.0×FY 2016: 0.2×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.1×
FY 2011 5y median 0.0× FY 2020
Quick Ratio 0.1×
FY 2011: 3.8×FY 2012: 2.2×FY 2013: 0.2×FY 2014: 0.2×FY 2015: 0.0×FY 2016: 0.2×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.1×
FY 2011 5y median 0.0× FY 2020
Debt / Equity -0.3×
FY 2011: 0.0×FY 2012: 0.0×FY 2013: 0.0×FY 2014: -0.4×FY 2015: -0.2×FY 2016: -0.3×FY 2017: -0.3×FY 2018: -0.2×FY 2019: -0.3×FY 2020: -0.3×
FY 2011 5y median -0.3× FY 2020
Net Debt / EBITDA -0.7×
FY 2011: 0.7×FY 2012: 0.3×FY 2013: 0.0×FY 2014: -0.1×FY 2015: -0.3×FY 2016: -0.0×FY 2017: -0.6×FY 2018: -2.2×FY 2019: -1.4×FY 2020: -0.7×
FY 2011 5y median -0.7× FY 2020
Interest Coverage -22.0×
FY 2011: -1347×FY 2012: -2076×FY 2013: -8958×FY 2014: -37.8×FY 2015: -37.7×FY 2016: -16.4×FY 2017: -103×FY 2018: -13.0×FY 2019: -19.1×FY 2020: -22.0×
FY 2011 5y median -19.1× FY 2020

Dividends

Dividend Yield 0.0%
FY 2011: 0.0%FY 2012: 0.0%FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 38.5%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%
FY 2011 5y median 0.0% FY 2020
Payout Ratio 0.0%
FY 2011: 0.0%FY 2012: 0.0%FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: -26.8%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%
FY 2011 5y median 0.0% FY 2020

Annual · latest fiscal year ends 2020-12-31